BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang ZN, Chen JM, Huang LC, Fang YH, Her LS. Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model. Mol Neurobiol 2021;58:2704-23. [PMID: 33492644 DOI: 10.1007/s12035-020-02280-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 George M, Tharakan M, Culberson J, Reddy AP, Reddy PH. Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases. Ageing Research Reviews 2022;82:101756. [DOI: 10.1016/j.arr.2022.101756] [Reference Citation Analysis]
2 Ivanenko KA, Prassolov VS, Khabusheva ER. Transcription Factor Sp1 in the Expression of Genes Encoding Components of Mapk, JAK/STAT, and PI3K/Akt Signaling Pathways. Mol Biol 2022;56:756-769. [DOI: 10.1134/s0026893322050089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Solés-tarrés I, Cabezas-llobet N, Lefranc B, Leprince J, Alberch J, Vaudry D, Xifró X. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington’s Disease Models: Role of PAC1 Receptor. Front Pharmacol 2022;12:797541. [DOI: 10.3389/fphar.2021.797541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 George DE, Tepe JJ. Advances in Proteasome Enhancement by Small Molecules. Biomolecules 2021;11:1789. [PMID: 34944433 DOI: 10.3390/biom11121789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Tung CW, Huang PY, Chan SC, Cheng PH, Yang SH. The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease. J Biomed Sci 2021;28:59. [PMID: 34412645 DOI: 10.1186/s12929-021-00755-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 D'Mello SR. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease. Int J Mol Sci 2021;22:5911. [PMID: 34072862 DOI: 10.3390/ijms22115911] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]